» Articles » PMID: 36282941

Surface Presentation of Hyaluronic Acid Modulates Nanoparticle-Cell Association

Overview
Journal Bioconjug Chem
Specialty Biochemistry
Date 2022 Oct 25
PMID 36282941
Authors
Affiliations
Soon will be listed here.
Abstract

Nanoparticle (NP) drug carriers have revolutionized medicine and increased patient quality of life. Clinically approved formulations typically succeed because of reduced off-target toxicity of the cargo. However, increasing carrier accumulation at disease sites through precise targeting remains one of the biggest challenges in the field. Novel multivalent ligand presentations and self-assembled constructs can enhance cell association, but an inability to draw direct comparisons across formulations has hindered progress. Furthermore, how nanoparticle structure influences function often is unclear. In this report, we leverage the well-characterized hyaluronic acid (HA)-CD44 binding pair to investigate how the surface architecture of modified NPs impacts their association with ovarian cancer cells that overexpress CD44. We functionalized anionic liposomes with 5 kDa HA by either covalent conjugation via surface coupling or electrostatic self-assembly using the layer-by-layer (LbL) adsorption method. Comparing these two methods, we observed a consistent enhancement of NP-cell association with the self-assembly LbL technique, particularly with higher molecular weight (≥10 kDa) HA. To further optimize association, we increased the surface-available HA. We synthesized a bottlebrush glycopolymer composed of a polynorbornene backbone and pendant 5 kDa HA and layered this macromolecule onto NPs. Flow cytometry revealed that the LbL HA bottlebrush NP outperformed the LbL linear display of HA. Cellular visualization by deconvolution optical microscopy corroborated results from all three constructs. Using exogenous HA to block NP-CD44 interactions, we found the LbL HA bottlebrush NP had a 4-fold higher binding avidity than the best-performing LbL linear HA NP. We further observed that decreasing the density of HA bottlebrush side chains to 75% had minimal impact on LbL NP stability or cell association, though we did see a reduction in binding avidity with this side-chain-modified NP. Our studies indicate that LbL surfaces are highly effective for multivalent displays, and the mode in which they present a targeting ligand can be optimized for NP cell targeting.

Citing Articles

Targeted Nanocarrier-Based Drug Delivery Strategies for Improving the Therapeutic Efficacy of PARP Inhibitors against Ovarian Cancer.

Gralewska P, Gajek A, Marczak A, Rogalska A Int J Mol Sci. 2024; 25(15).

PMID: 39125873 PMC: 11312858. DOI: 10.3390/ijms25158304.


Hyaluronic Acid Nanoparticles with Parameters Required for Applications: From Synthesis to Parametrization.

Matejkova N, Korecka L, Salek P, Kockova O, Pavlova E, Kasparova J Biomacromolecules. 2024; 25(8):4934-4945.

PMID: 38943654 PMC: 11323013. DOI: 10.1021/acs.biomac.4c00370.


Electrostatic adsorption of polyanions onto lipid nanoparticles controls uptake, trafficking, and transfection of RNA and DNA therapies.

Nabar N, Dacoba T, Covarrubias G, Romero-Cruz D, Hammond P Proc Natl Acad Sci U S A. 2024; 121(11):e2307809121.

PMID: 38437543 PMC: 10945854. DOI: 10.1073/pnas.2307809121.


Layer-by-Layer Polymer Functionalization Improves Nanoparticle Penetration and Glioblastoma Targeting in the Brain.

Pickering A, Lamson N, Marand M, Hwang W, Straehla J, Hammond P ACS Nano. 2023; 17(23):24154-24169.

PMID: 37992211 PMC: 10964212. DOI: 10.1021/acsnano.3c09273.

References
1.
Bangham A, Standish M, Watkins J . Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965; 13(1):238-52. DOI: 10.1016/s0022-2836(65)80093-6. View

2.
Blanco E, Shen H, Ferrari M . Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015; 33(9):941-51. PMC: 4978509. DOI: 10.1038/nbt.3330. View

3.
Song E, Gaudin A, King A, Seo Y, Suh H, Deng Y . Surface chemistry governs cellular tropism of nanoparticles in the brain. Nat Commun. 2017; 8:15322. PMC: 5454541. DOI: 10.1038/ncomms15322. View

4.
Lundquist J, Toone E . The cluster glycoside effect. Chem Rev. 2002; 102(2):555-78. DOI: 10.1021/cr000418f. View

5.
Eliaz R, Szoka Jr F . Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells. Cancer Res. 2001; 61(6):2592-601. View